NIH awards $1.38M to professor for HIV vaccine research

National Institutes of Health doled out $1.38 million to a University of Kansas faculty member for HIV vaccine research. Heather Desaire, a chemistry professor, will use the money to investigate several candidate vaccines alongside researchers from Duke University Medical Center and Harvard Medical Center. Story

Suggested Articles

Merck has a big target in mind for its pneumococcal vaccine V114: Prevnar 13, the world's best-selling shot—and its phase 3 program shows it.

A Lancet Infectious Diseases study shows antibody response persists for two years or more after a single shot of Merck’s rVSV-ZEBOV vaccine.

Behind the under-pressure blockbuster Prevnar 13 are several pipeline vaccines Pfizer hopes will propel future growth.